Energy Manager
4 days ago
Governor's Highway Safety Chair, Michael Hanson on Oral Fluid Testing before Congress...
Governors Highway Safety Association
Β·
⚠️ 📰 🛣️ ICYMI: GHSA Chair Michael Hanson, Director of the Minnesota Office of Traffic Safety, testified about roadway safety on Capitol Hill last week. During the three-hour hearing, Hanson spoke about the state of U.S. traffic safety, whatβs working and whatβs not. Here are a few key highlights:
💡 PROMOTING INNOVATION: Rep. Greg Stanton singled out the need for innovation in Section 402 funding. Hanson urged lawmakers to give State Highway Safety Offices more flexibility to deploy creative solutions and data-driven countermeasures so they can most efficiently use federal dollars. βThis is where the behavior part and the infrastructure part come together, and anything we can do to help support our infrastructure partners is going to be a step in the right direction,β he said. Hanson told lawmakers that emerging technologies and data analysis can provide real-time safety insights that will improve safety.
🚓 TRAFFIC ENFORCEMENT: Both Republican and Democratic subcommittee members voiced support for the enforcement of traffic safety laws. Hanson told lawmakers that βGHSA supports the proven role of traffic enforcement and the wider criminal justice system in preventing crashes and stopping dangerous drivers.β Separately, responding to a question from Rep. Pete Stauber, Hanson said: βThe data is irrefutable. The decrease in traffic law enforcement thatβs happened over the last five, six, seven years across the country has led to significant increases in the bad driving behavior weβre seeing out there.β
🍸 IMPAIRED DRIVING: How to prevent impaired driving was brought up several times at the hearing. Responding to a question from Rep. Jerry Nadler, Hanson said that passive impaired driving prevention technology would save 10,000 lives a year, the technology is ready and that βanything we can deploy to prevent an impaired driving incident from happeningβ is critical. Hanson echoed Nadlerβs remark that impaired driving prevention technology is a βgame-changer.β Separately, responding to a question about cannabis-impaired driving, Hanson said that oral fluid testing has been successful in addressing this critical safety issue.
Thanks to Chair Hanson for doing such a great job flying the roadway safety flag before Congress!
Energy Manager
5 days ago
Pennsylvania - There were also multiple back-and-forths between the officials and lawmakers about public safety concernsβparticularly as it concerns impaired driving. And the takeaway was generally that while the continued lack of a tool to detect active impairment from THC is problematic, there are other methods of ensuring road safety, including the utilization of drug recognition experts, or DREs.
At a House Appropriations Committee hearing, Lt. Col. George Bivens recognized that state police are βgoing to need additional resources, particularly in the patrol function, with regards to highway safety and then on the investigative side.β He said the department has spoken to colleagues in other states that have enacted legalization about the issue.
https://www.marijuanamoment.net/top-pennsylvania-police-and-health-officials-say-theyre-prepared-to-implement-marijuana-legalization/?fbclid=IwY2xjawIpkdlleHRuA2FlbQIxMQABHa798exs41Uho7I2Ghz0OjasSC2U1nj2MQGn4cVlKw4eaYFV6MSOgWCrog_aem_N4uBOHPgX-e0txd5fkCpgg
Energy Manager
6 days ago
Germany's law sets the cut-off limit for THC at 3.5ng/ml in blood. This is law. As technology advances, I believe we will see a shift from blood to oral fluid sample tests, which have been proven to effectively measure recent use of THC vs. blood, urine, hair - giving results that may be up to 30 days since use.
Technology may further advance to things like breath sample tests in the future. This is an evolving technology, but society wants and needs this technology. Governments needs to be held accountable for the effects of legalizing marijuana, on the safety of it's citizens.
Debate is good for stocks - it creates volume and volatility. Since this stock is over 90% owned by insiders, sellers are on the wrong side of the trade.
https://cannabislaw.report/germany-announces-new-thc-limit-in-road-traffic-effective-immediately/
Energy Manager
6 days ago
No, because this has been the debate for a long time. The oral fluid sample test is the best option we have to date, and is a much better option than a zero tolerance.
The U.S. department of Transportation has felt strongly enough to apply a cut-off limit for THC at 4ng/ml, and Germany has followed suit. This will be an evolving issue, and I'm sure there will be further debate. It may be that oral fluid tests are initially used as a compliment to Drug Recognition Experts. We know that marijuana use impairs driving, I don't think anyone will argue that. There were similar arguments when the alcohol breathalyzer became mainstream - people argued that daily drinkers had a better tolerance for alcohol, and were better drivers, despite their BAC levels.. People argued that if you consumed a large meal, or drank coffee, took a shower, etc., that your driving would not be impaired by drinking alcohol. It's simply not the case.
Don't second guess yourself on this...
pdicamillo1
1 week ago
Quick Lifeloc thoughts:
- Believe it or not, Friday was the largest volume day in over 6 months. Sadly all the volume was on the sell side. I can't fathom who is still selling shares at these prices with all the upcoming events.
- Does anyone actually believe Cannabix is currently worth 4 times the value of Lifeloc? Is the Cannabix marijuana breathalyzer device worth 4 times that of the entire Lifeloc alcohol breathalyzer business and the SpinDx drug detection device? Not a chance. It shows you the value of providing updates and having concern for shareholder value.
- I still think that AXON who has emerged as a standout player in the tech-driven future of public safety would be a great merger and/or acquisition partner. AXON is valued at 5,000 times that of Lifeloc. AXON could partner or merge with Lifeloc for pocket change.
- I really would like to see some updates from management about the development status of the SpinDx. There has not been any buying interest in this stock for months. Sometimes I feel like I am the only investor that has any bids in and continues to buy shares. Can we please get some new investor interest in this company? You would think with Vern getting up there in age and being the largest shareholder by far, he would push a bit for putting out some updates and want to get things moving.
- Thinking into the future - Since the SpinDx device has the capability of testing 64 different assays, I can't help but think this would be a fantastic device for hospitals to have on hand for a quick test of not only drugs of abuse but things like Lymes disease, mold toxins, covid, viral and bacterial infections, etc. 64 potential tests is more than adequate to pre-screen a patient and determine what might be the issue.
pdicamillo1
1 week ago
βWith states getting out in front of federal legislation relating to marijuana specifically,β he said, βdo you have any recommendations or ideas or technologies that we can start to implement that would detect a more instantaneous level of impairment?β
I think we all know of a certain technology called the SpinDx that is capable of detecting an instantaneous and quantitative level of impairment. Sadly it's only a handful of people that know about this device. We are in the sweet spot for dissemination of this information.
"Though thereβs no widely agreed-upon way to test impairment by drivers at a roadside stop, efforts to develop and deploy field tests that screen for recent use have become more urgent in recent years."
"The National Institute of Standards and Technology (NIST), for instance, is planning to convene government officials, forensics experts, academics, industry representatives, law enforcement and standards organizations in April for what it describes as βan open and candid discussionβ about βthe path forward to realize meaningful cannabis breathalyzer technology and implementation.β
This NIST event is the absolute perfect time and place for LIfeloc to start introducing the SpinDx device to those that are waiting for it.
Energy Manager
1 week ago
Traffic Safety Official Emphasizes Need For Roadside Marijuana Testing At Congressional Transportation Hearing. We should start to see an uptick, as the debate begins. There's a lot of stimulus coming in the next few months - trade shows, conventions, NIST meeting, Congress, Beta testing, Quarterly/Yearly reports.
It won't be long before the media starts to gain attention, and report on this... The much needed focus on transportation safety, as a result of legalization/decriminalization of marijuana in the United States.
https://www.marijuanamoment.net/traffic-safety-official-emphasizes-need-for-roadside-marijuana-testing-at-congressional-transportation-hearing/?fbclid=IwY2xjawImsvJleHRuA2FlbQIxMQABHSf0fEmsPl8_AI-hXEuJrg6UAe_Lbet0rVDRwoU1mgz95pcCkdCgaFHafA_aem_PLX6HG-RxPOxpSluDJBbaQ
Energy Manager
2 weeks ago
Lifeloc has demonstrated down to 5 ng/ml, and is working on narrowing that down. Draeger's device is pass/fail only - very similar to a pregnancy test strip that turns a different color if positive, vs Lifeloc's SpinDx device giving an xx ng/ml quantitatively. I expect Lifeloc's initial release to be a pass/fail, and later update to a quantitative disc, ultimately end product being a quantitative device as a breathalyzer unit - adding quantitative discs for additional drugs of abuse, with endless sales of consumable discs, collection kits, and firmware upgrades. $$$$$
Lifeloc has existing sales of their alcohol breathalyzers all over the world - to over 65 countries. If customers want consistency in a product, I would say Lifeloc has that wrapped up.
If Lifeloc makes it another year without being acquired by Draeger, it could quite possibly eventually acquire Draeger....
Energy Manager
2 weeks ago
Wanted: A test for THC impairment - Indiana was originally going to set the cut-off limit for THC at 5ng/ml, but amended it to using the saliva test for THC as a complimentary means to sobriety tests, weaving, blood tests, etc., until the science is better understood...
https://indianacapitalchronicle.com/2025/02/13/lawmakers-move-thc-test-threshold-for-impaired-driving/
The controversy continues. Hopefully we will get a move in the right direction, after the NIST meeting of the minds in April.
pdicamillo1
2 weeks ago
This is what I have for upcoming Conferences/Expos that Lifeloc will be attending and hopefully presenting the new SpinDx Drug Detection Device Technology:
National Institute of Standards and Technology (NIST), is scheduled to be held in Boulder, Colorado, on April 16 and 17.
NDASA 2025 Annual Conference & Trade Show Jacksonville, FL April 1-3
2025 Lifesavers Conference - Long Beach Convention Center, Long Beach, California - March 9 β 11, 2025
2025 Symposium on Traffic Safety May 19-22, 2025 Lake Buena Vista, Florida
2025 IACT Annual Conference - April 6 - 11, 2025 | Sahara Las Vegas | 2535 Las Vegas Blvd S. | Las Vegas, NV
Energy Manager
4 weeks ago
Diamond Bridge has the first right of refusal on future debenture financing, so most likely, any future funding could possibly come from them. The terms were very good, 8.25% loan is good terms for business loan, as I have stated before, and it is unsecured, and relatively non-dilutive - except for the warrants, which were used to "sweeten the deal" I'm sure. It also gives Lifeloc the flexibility to issue more warrants to Diamond Bridge, if they opt for future, interest only payments.
As far as Adam Kashenberg - he will be compensated as all other Directors of Lifeloc. Insiders buy and sell stock for a variety of reasons, and we do not know anything about his current financial status. As far as I'm concerned, it's irrelevant at this point.
Yes, the stock, as any stock, would benefit from a rise in share price. Lifeloc is a small company, with a very small share structure and float. It sometimes will go days without a single trade, and this illiquidity is unattractive to most investors. The share price would definitely benefit from some positive news from the company, thus increasing volume and price - which would most likely attract new investors and traders. With an increase in share price in the future, the stock would greatly benefit from a stock split, thus increasing shares in a non-dilutive manner, as well as help it meet requirements for uplisting.
As far as the video for the alcohol breathalyzer goes, I believe it was a smart business decision. The alcohol segment of their business has almost completely funded the development of the SpinDX device, and to abandon that, would not be a smart move, particularly showcasing the advancements and capabilities of the LT7 and LX9 to date. It also opens doors to future videos and marketing for the SpinDx device by the production company.
I believe there has been an abundance of shares being sold short in January. Whether this is Diamond Bridge putting a sell trade on, to protect them from downside risk, I don't know. But, I try not to micro-manage every small thing in my investments. Yes, it's good to stay on top of your investments, but I believe there are big things to come here, and that is what we should all focus on...
Energy Manager
1 month ago
This is simply a first step, in what will hopefully grow into a much broader, and more aggressive approach to their product branding.
This past summer, Lifeloc appointed Adam Kashenberg to it's board of directors. Supposedly, he is well versed in social media sales and marketing. It's a start, and I doubt Lifeloc would blatantly invest time and money into a marketing endeavor, and not follow through with it. I would expect to see this marketing expand very quickly of their oral fluid device, once it is released.
This is a time to get excited about the near future, not frustrated. Lifeloc has made monumental progress in their product development, and is now preparing for production of their device. With their provisional patent filed in August, they basically are on a tight timeline to file for a nonprovisional, full patent in the next 6 months.
Lifeloc has un-doubtedly made the correct decision to focus their efforts to oral fluid testing for the near term. Oral fluid testing is the current trend in drug testing, and Lifeloc's device will be at the forefront, with one of the only devices available, giving a quantitative reading of THC.
pdicamillo1
1 month ago
As of today, does cocaine, opiates, fentanyl, amphetamine, methamphetamine, morphine, MDMA, and benzodiazepines have any known cut-off limits for driving while intoxicated and/or on the work clock?
Thanks!
Energy Manager
1 month ago
The key factor here is the cut-off limit for THC. Oral fluid tests provide a much more recent window of detection vs blood, urine, hair, etc... Along with this cut-off limit is where Lifeloc's device really shines, compared to other oral fluid tests. Since Lifeloc's device gives a quantitative result, it can give a much more accurate result for recent use. Currently, the DOT has set the cutoff limit for THC at 4ng/ml.
I believe individual states will begin to follow the DOT ruling, and set similar limits for their states. The test results will then be used in a similar manner as results from an alcohol breathalyzer. If the concentration is above the limit, you will be considered under the influence, if below, than not..
Energy Manager
1 month ago
I believe that the disc is only going to be temporarily produced by the large, microfluidics company, with some of the money recently acquired being used to provide manufacturing capability to develop the discs in house.
This most likely enables Lifeloc to hit the ground running, with a small batch manufacturer in place, which will provide the discs for rollout, until their manufacturing facility is ready for full-scale production - which will be the most cost effective for Lifeloc, and give them a more adaptive, in house means for future development and production, of discs with the capability to detect other drugs of abuse, such as methamphetamines, cocaine, fentanyl, Heroin, etc...
pdicamillo1
1 month ago
In the latest PR from Lifeloc they state, "Lifeloc expects the analytical disk to be produced and supplied in small quantities by a large international microfluidics company."
Some of the top companies leading the microfluidic immunoassay industry for medical testing include Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, QIAGEN, and Thermo Fisher Scientific. These companies are renowned for their innovative technologies and comprehensive solutions that revolutionize medical testing processes worldwide, offering faster, more accurate, and more accessible diagnostic capabilities.
Wouldn't it be nice to one day wake up to the headline that Lifeloc Technologies will be working with Abbott Labs to produce an analytical disk for their new and innovative SpinDx drug detection technology.
One can always dream.
Energy Manager
1 month ago
It appears that the FORM D is totally inclusive of the Diamond Bridge Deal. The total amount sold is the $750,000 loan + 62,500 warrants ($281,250) = $1,031,250. The total remaining sold reflects the terms of the debenture agreement, where Lifeloc has the option to pay quarterly interest, in lieu of monthly payments. If they do this, they must issue Diamond Bridge more warrants as described.
Manner and Time of Payment. The Subordinated Debt shall be payable as follows: (a) Borrower shall make
quarterly interest-only payments in the amount of $15,468.75 per quarter on March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025; (b)
beginning January 31, 2026, Borrower shall make monthly payments in the amount of $9,198.95 per month, reflecting principal plus interest based on the
amortization schedule attached hereto as Exhibit C, calculated on the basis of a 10-year amortization period; provided that Borrower shall have the right to
make interest payments quarterly instead of monthly upon notice to Lender and provided that Borrower shall issue to Lender additional Warrants to purchase
up to 20,000 shares of Common Stock for each quarter in which payments are not made monthly, up to a maximum of 62,000 Warrants issued under this
provision in any first year that Borrower exercises that right and 7,800 Warrants per quarter thereafter; and (c) the balance due on the Maturity Date